Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multi-Center Acute Safety Trial of TactiCath™ Contact Force Ablation Catheter, Sensor Enabled™ (TactiCath SE) for the Treatment of Drug Refractory Recurrent Symptomatic Paroxysmal Atrial Fibrillation

NCT03354663 is registered in ClinicalTrials.gov with Abbott Medical Devices as lead sponsor.

NCT NCT03354663
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03354663 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multi-Center Acute Safety Trial of TactiCath™ Contact Force Ablation Catheter, Sensor Enabled™ (TactiCath SE) for the Treatment of Drug Refractory Recurrent Symptomatic Paroxysmal Atrial Fibrillation
Lead sponsor
Abbott Medical Devices
Phase
Not applicable
Overall status
Completed
Start date
December 11, 2017
Completion date
October 30, 2019
Enrollment
156 (actual)
Sites
21

Conditions

As the registry lists them; a condition with its own page is linked.

paroxysmal atrial fibrillation